Yemen Health Report: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Yemen Health Report.

January 2026

Mo	Tu	We	Th	Fr	Sa	Su
			1	2	3	4
5	6	7	8	9	10	11
12	13	14	15	16	17	18
19	20	21	22	23	24	25
26	27	28	29	30	31

February 2026

Mo	Tu	We	Th	Fr	Sa	Su
						1
2	3	4	5	6	7	8
9	10	11	12	13	14	15
16	17	18	19	20	21	22
23	24	25	26	27	28

March 2026

Mo	Tu	We	Th	Fr	Sa	Su
						1
2	3	4	5	6	7	8
9	10	11	12	13	14	15
16	17	18	19	20	21	22
23	24	25	26	27	28	29
30	31

Press releases published on March 17, 2026

Mar. 17, 2026

Tonix Pharmaceuticals Announces Oral Presentation and Two Poster Presentations on Preclinical Immuno-oncology Portfolio at the American Association for Cancer Research (AACR) Annual Meeting 2026

GlobeNewswire

Mar. 17, 2026

Prelude Therapeutics Announces Acceptance of Preclinical Abstract for PRT13722, a First-in-Class Oral KAT6A Selective Degrader at the 2026 AACR Annual Meeting

GlobeNewswire

Mar. 17, 2026

Immunocore will present five-year overall survival data for KIMMTRAK during oral presentation at the 2026 AACR meeting

GlobeNewswire

Mar. 17, 2026

Enara Bio to Unveil First‑in‑Class DARKFOX‑Targeting Bispecific T Cell Engager ENA101 in Oral Presentation at AACR 2026, Showcasing Breakthrough Potential for Solid Tumor Immunotherapy

GlobeNewswire

Mar. 17, 2026

Zentalis Pharmaceuticals to Present Two Posters at the American Association for Cancer Research (AACR) Annual Meeting 2026

GlobeNewswire

Mar. 17, 2026

Evaxion to present new data at AACR Annual Meeting

GlobeNewswire

Mar. 17, 2026

SELLAS Life Sciences to Present Preclinical Data Highlighting Potent Activity of SLS009 in AML at the 2026 AACR Conference

GlobeNewswire

Mar. 17, 2026

Anbio Biotechnology to Participate in KeyBanc Capital Markets Healthcare Forum

GlobeNewswire

Mar. 17, 2026

Olema Oncology to Present Preclinical Data for Palazestrant and OP-3136 at the 2026 AACR Annual Meeting

GlobeNewswire

Mar. 17, 2026

Akari Therapeutics Announces ADS Ratio Change

GlobeNewswire

Mar. 17, 2026

ImageneBio Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswire

Mar. 17, 2026

Molecular Partners to Hold Three Poster Presentations at AACR 2026

GlobeNewswire

Mar. 17, 2026

BlossomHill Therapeutics Unveils New Pan-KRAS Inhibitor Programs and Announces Upcoming Presentations at AACR Annual Meeting 2026

GlobeNewswire

Mar. 17, 2026

Longeveron Announces 2025 Full Year Financial Results and Provides Business Update

GlobeNewswire

Mar. 17, 2026

Synergy CHC Corp. Announces Fourth Quarter and Full Year 2025 Earnings and Conference Call Information

GlobeNewswire

Mar. 17, 2026

Trevi Therapeutics Reports Fourth Quarter and Year End 2025 Financial Results and Provides Business Updates

GlobeNewswire

Mar. 17, 2026

Myriad Genetics Receives FDA Approval of the MyChoice CDx Test as the Companion Diagnostic for Zejula (niraparib) for Patients with Ovarian Cancer

GlobeNewswire

Mar. 17, 2026

Kestra Medical Technologies Reports Third Quarter Fiscal 2026 Financial Results

GlobeNewswire

Mar. 17, 2026

HealthEquity Reports Record Revenue, Earnings and New HSAs From Sales for Fourth Quarter and Year Ended January 31, 2026, Resulting in Raised Fiscal 2027 Outlook

GlobeNewswire

Mar. 17, 2026

SAB BIO Announces Proposed Public Offering of Common Stock and Pre-Funded Warrants

GlobeNewswire